Jasper Ridge Partners, L.P. Mirum Pharmaceuticals, Inc. Transaction History
Jasper Ridge Partners, L.P.
- $3.18 Billion
- Q1 2024
A detailed history of Jasper Ridge Partners, L.P. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Jasper Ridge Partners, L.P. holds 8,206 shares of MIRM stock, worth $300,339. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,206
Previous 25,825
68.22%
Holding current value
$300,339
Previous $762,000
72.97%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$238 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$160 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$121 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$101 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.35B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...